Literature DB >> 28238542

Aberrant expression of cell cycle and material metabolism related genes contributes to hepatocellular carcinoma occurrence.

Hongxian Yan1, Zhaohui Li2, Quan Shen3, Qian Wang4, Jianguo Tian3, Qingfeng Jiang3, Linbo Gao5.   

Abstract

This study aims to deepen our understanding of the molecular mechanism underlying the occurrence of hepatocellular carcinoma (HCC). We first downloaded a gene expression profile dataset GSE29721 (10 HCC and 10 control samples) from Gene Expression Omnibus database (http://www.ncbi.nlm.nih.gov/geo/). Differentially expressed genes (DEGs) were identified by the paired t-test using limma package. Pathway and functional enrichment analyses were performed with DAVID tools. Transcription factors were annotated with TRANSFAC database and tumor associated genes (TAGs) were annotated with TAG and TSGene databases. Protein-protein interaction (PPI) network was conducted using STRING online tool and function module was further identified with BioNet package. Totally, 527 up-regulated DEGs and 587 down-regulated DEGs were identified. GO functional and KEGG pathway enrichment analyses showed that the up-regulated DEGs were mainly related to cell division and cell cycle, while the down-regulated DEGs were largely related to material metabolism, especially secondary metabolism. Proteins encoded by DEGs CDK1, BUB1, CDC20, NCAPG, NDC80, CDCA8, MAD2L1, CCNB1, CCNA2 and BIRC5 were hub genes with high degrees in the PPI network; further module analysis detected a subnetwork consisting of 55 proteins, such as CYP2B6, ACAA1, BHMT and ALDH2. Taken together, aberrant expression of cell cycle related genes (e.g., CDK1, CCNA2, CCNB1, BUB1, MAD2L1 and CDC20) and material metabolism related genes (e.g., CYP2B6, ACAA1, BHMT and ALDH2) may contribute to HCC occurrence.
Copyright © 2017 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Differentially expressed genes; Functional enrichment analysis; Hepatocellular carcinoma; Pathway enrichment analysis; Protein-protein interaction

Mesh:

Year:  2017        PMID: 28238542     DOI: 10.1016/j.prp.2017.01.019

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  27 in total

1.  Identification and validation of ferroptosis-associated gene-based on immune score as prognosis markers for hepatocellular carcinoma patients.

Authors:  Jukun Wang; Ke Han; Chao Zhang; Xin Chen; Yu Li; Linzhong Zhu; Tao Luo
Journal:  J Gastrointest Oncol       Date:  2021-10

2.  A systems pharmacology approach based on oncogenic signalling pathways to determine the mechanisms of action of natural products in breast cancer from transcriptome data.

Authors:  Regan Odongo; Asuman Demiroglu-Zergeroglu; Tunahan Çakır
Journal:  BMC Complement Med Ther       Date:  2021-06-30

3.  Prognostic comparative genes predict targets for sorafenib combination therapies in hepatocellular carcinoma.

Authors:  Chun-Ming Ho; Kuen-Tyng Lin; Roger Shen; De-Leung Gu; Szu-Shuo Lee; Wen-Hui Su; Yuh-Shan Jou
Journal:  Comput Struct Biotechnol J       Date:  2022-04-09       Impact factor: 6.155

4.  Transcriptome Analysis Revealed a Highly Connected Gene Module Associated With Cirrhosis to Hepatocellular Carcinoma Development.

Authors:  Shan Shan; Wei Chen; Ji-Dong Jia
Journal:  Front Genet       Date:  2019-04-02       Impact factor: 4.599

5.  Overexpression of CDCA8 promotes the malignant progression of cutaneous melanoma and leads to poor prognosis.

Authors:  Chao Ci; Biao Tang; Dalun Lyu; Wenbei Liu; Di Qiang; Xiang Ji; Xiamin Qiu; Lei Chen; Wei Ding
Journal:  Int J Mol Med       Date:  2018-11-07       Impact factor: 4.101

6.  Study of Gene Expression Profiles of Breast Cancers in Indian Women.

Authors:  Shreshtha Malvia; Sarangadhara Appala Raju Bagadi; Dibyabhaba Pradhan; Chintamani Chintamani; Amar Bhatnagar; Deepshikha Arora; Ramesh Sarin; Sunita Saxena
Journal:  Sci Rep       Date:  2019-07-10       Impact factor: 4.379

7.  Nuclear division cycle 80 promotes malignant progression and predicts clinical outcome in colorectal cancer.

Authors:  Xuebing Yan; Linsheng Huang; Liguo Liu; Huanlong Qin; Zhenshun Song
Journal:  Cancer Med       Date:  2018-01-17       Impact factor: 4.452

8.  Expression of the Long Intergenic Non-Protein Coding RNA 665 (LINC00665) Gene and the Cell Cycle in Hepatocellular Carcinoma Using The Cancer Genome Atlas, the Gene Expression Omnibus, and Quantitative Real-Time Polymerase Chain Reaction.

Authors:  Dong-Yue Wen; Peng Lin; Yu-Yan Pang; Gang Chen; Yun He; Yi-Wu Dang; Hong Yang
Journal:  Med Sci Monit       Date:  2018-05-05

9.  CDCA8 expression and its clinical relevance in patients with bladder cancer.

Authors:  Yaqiong Bi; Song Chen; Jiazhi Jiang; Jie Yao; Gang Wang; Qiang Zhou; Sheng Li
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

10.  Nine hub genes related to the prognosis of HBV-positive hepatocellular carcinoma identified by protein interaction analysis.

Authors:  Wenhui Xie; Bin Wang; Xiaoting Wang; Diyu Hou; Huiyan Su; Huifang Huang
Journal:  Ann Transl Med       Date:  2020-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.